- Share this article on Facebook
- Share this article on Twitter
- Share this article on Email
- Show additional share options
- Share this article on Print
- Share this article on Comment
- Share this article on Whatsapp
- Share this article on Linkedin
- Share this article on Reddit
- Share this article on Pinit
- Share this article on Tumblr
The 25th James Bond currently sits on £85.9 million ($117.3 million) exactly a month after its Nov. 1 release, just $3.8 million shy of Endgame‘s grand total of £88.7 million ($121.1 million). With $4.8 million amassed in its fifth weekend ending Oct. 31 — a drop of 25 percent — the position switch is expected to happen over the course of the next week, especially with U.K. cinemas not facing any COVID-19 related capacity restrictions.
These figures are no small achievement for No Time to Die and its worldwide distributor, Universal, with the film carrying a huge weight of expectations as the biggest tentpole release since the reopening of cinemas post-pandemic. Although the U.K. has traditionally been a huge market for 007, given the unique scenario this film faced, few genuinely expected it to match 2019’s Endgame — the biggest release prior to the COVID-19 crisis — let alone beat it.
No Time to Die will now join Skyfall (second place, at £103.2 million) and Spectre (third place, £95.2 million) as the third Bond title in the U.K.’s top five. The two remaining films are Star Wars: The Force Awakens (£123.2 million) in first place and Avatar (£94 million) in fourth. Whether No Time can match its 007 counterparts is still up in the air — it’s currently in line with both Skyfall and Spectre at the comparable points in their run.
Globally, No Time to Die has now passed the $600 million milestone, the most recent bulk of receipts coming from China, where it debuted to an estimated $28.2 million.
Sign up for THR news straight to your inbox every day